P.T. Astellas Pharma Indonesia
アステラスファーマインドネシア株式会社Alias
Ticker
—
Listed market
—
Country
Employees (non-consolidated)
—
Related companies
2
§01
Basic information
- Head office
- Jakarta, Indonesia
- Chief executive
- Naoki Okamura
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- End date
§02
Websites
§03
Business
Products and Disease AreasRx+ Business CreationImproving Availability of Astellas ProductsSustainability in Business ActivitiesCancer TreatmentOphthalmology TreatmentUrological Disease TreatmentImmunotherapyWomen's Health Treatment
§04
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
| Iveric Bio |
Names without a link are companies not yet registered in OpenBizGraph
§05
Network
Drag to move · click to open
§06
History
Leaders from Yamanouchi and Fujisawa shake hands, marking the 2005 merger that formed Astellas and shaped a patient-first global strategy. Astellas was established in April 2005 through the merger of two companies – Yamanouchi Pharmaceutical (founded in 1923) and Fujisawa Pharmaceutical (founded in 1894).
In April 2025, Astellas celebrated our 20th Anniversary as a company.
§07
News
There is no news.
§09
Sources & updates
DOMAINOwn domain：No
UPDATED2026-10-17 14:56 · Model: ggml-org/gpt-oss-20b